argenx SE
argenx SE (ARGNF) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · ARGNF · as of Jun 8, 2026
Key Statistics
Explore argenx SE Data
argnf stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 24 · Buy rate: 87.5%
Competitors & Peers
argnf competitorsARGNF
CMXHF
DSKYF
DSNKY
HOCPF
IPSEYStock Performance
Full HistoryAbout argenx SE
argenx SE operates as a biotechnology firm, specializing in the advancement of various therapeutic solutions for autoimmune diseases across the United States, the Netherlands, Belgium, Japan, Switzerl…
what is argenx se · argnf stock overview · argenx se company profile · who is argenx se ceo · argnf OTC · argenx se headquarters · argenx se business segments
About Stock Overview & Key Data
argenx SE (ARGNF) is a Healthcare company in the Biotechnology industry, listed on OTC since Apr 30, 2015. As of the latest trading session, ARGNF stock price is $885.00, with a market capitalization of $54.8B. The stock has returned +50.88% over the past 12 months and +1.72% year-to-date.
According to 24 Wall Street analysts, the consensus rating for argenx SE stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, argenx SE reported revenue of $4.3B and net income of $1.3B. For detailed data — including argenx SE revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, argenx SE (ARGNF) stock price is $885.00. The stock is traded on OTC under the ticker symbol ARGNF. The 52-week range is $532.40 – $885.00.